Pacira BioSciences Announces Participation in Key Healthcare Events

Author: Henry Turner Updated: 05-14-2025 08:16 AM

Pacira BioSciences to Engage in Upcoming Healthcare Conferences

Pacira BioSciences, Inc. (Nasdaq: PCRX), recognized for its dedication to innovative, non-opioid pain management solutions, has exciting news for the healthcare community. The company will actively participate in two significant conferences in the near future, showcasing their commitment to enhancing patient care and treatment options.

Details on Conference Participation

Pacira will be featured in an analyst-led fireside chat at the following healthcare conferences:

RBC Capital Markets Global Healthcare Conference

This conference is set to take place on a Wednesday at 8:30 AM ET. The RBC Capital Markets Global Healthcare Conference presents a vital opportunity for Pacira to discuss ongoing developments in non-opioid pain management.

Jefferies Global Healthcare Conference

Following closely, Pacira will also be part of the Jefferies Global Healthcare Conference on a Wednesday at 8:45 AM ET. This event will further allow the company to interact with analysts and showcase their innovative treatments.

Access to Live Audio and Webcast

For those interested in tuning in, live audio of the virtual events will be available. Interested parties can find more information on the company’s official events page. Additionally, a replay of these sessions will be accessible for two weeks post-event, ensuring that those unable to attend live can still benefit from the insights shared.

About Pacira BioSciences

At the heart of Pacira's operations is a focus on delivering non-opioid therapies that significantly improve the quality of life for patients facing pain. They offer a diverse range of commercial-stage treatments:

EXPAREL

EXPAREL (bupivacaine liposome injectable suspension) is a long-lasting local pain relief option approved for various forms of surgical pain management, including infiltration and nerve blocks.

ZILRETTA

ZILRETTA (triamcinolone acetonide extended-release injectable suspension) is useful for managing osteoarthritis pain in the knee, providing extended relief to patients.

iOVERA

Introducing the ioveraº device, this handheld solution offers immediate, drug-free pain relief targeting nerves through controlled cold therapy, underscoring Pacira's innovative approach to pain management.

Looking to the future, Pacira is advancing the potential of PCRX-201 (enekinragene inzadenovec), a groundbreaking gene therapy aimed at treating widespread conditions like osteoarthritis. This exciting development could represent a remarkable leap forward in therapeutic options.

For more information about Pacira BioSciences and their commitment to non-opioid solutions, visit their official website.

Frequently Asked Questions

What is the focus of Pacira BioSciences?

Pacira BioSciences focuses on delivering innovative non-opioid therapies to improve patient quality of life and pain management.

When will Pacira participate in the upcoming conferences?

Pacira will participate in the RBC Capital Markets Global Healthcare Conference and the Jefferies Global Healthcare Conference on specified dates at respective times.

How can I access the live audio of the events?

Live audio can be accessed through the Events page on the Pacira BioSciences website.

What treatments does Pacira currently offer?

Pacira offers treatments such as EXPAREL for surgical pain management, ZILRETTA for osteoarthritis knee pain, and the ioveraº device for cold therapy pain relief.

What is the significance of PCRX-201?

PCRX-201 is an innovative gene therapy under development aimed at treating large-scale diseases, like osteoarthritis, representing a significant advancement in treatment options.

About The Author

Hi there, As a writer and financial specialist, Henry Turner is passionate about guiding people through the complex world of finance. Having worked in finance for many years, I am an expert at simplifying difficult financial ideas into understandable, useful insights for my blog and articles. My goal is to arm you with the confidence and information you need to make wise financial choices.

Writing for a number of financial blogs has allowed me to interact with readers from novice investors looking for fresh ideas to seasoned investors starting their financial journeys. My mission is to enable everyone to understand and access finance, so enabling you to confidently and clearly reach your financial goals. I appreciate you traveling with me toward success and financial literacy.

Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.